Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Description

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.

The company offers Chinese medicine granules, finished pharmaceutical products, raw materials and excipients, medical devices, medical and healthcare services, and smart supply chain for pharmaceutical and medical devices.

It also provides its products in the areas of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases, as well as anti-tumor.

Tianjin Chase Sun Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Tianjin, China.

Tianjin Chase Sun Pharmaceutical Co.,Ltd

Country	China
Founded	1996
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	5,297
CEO	Dan Zheng

Contact Details

Address: Building B01, Entrepreneurial Headquarters Base Tianjin, 301700 China
Phone	86 22 5962 3160
Website	chasesun.cn

Stock Details

Ticker Symbol	300026
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100000GF1
SIC Code	2836

Key Executives

Name	Position
Dan Zheng	GM and Vice Chairman
Wu Jun Lan	Executive GM, Chief Financial Officer and Executive Director
Wu Sun	Deputy GM, Accounting Supervisor and Director
Chun Xu Li	Deputy GM, Chief Administrative Officer and Director
Rui Qiang Chen	GM of Human Resource Center and Deputy GM
Kun Zhang	Deputy General Manager
Xiao Zhong Lu	Deputy General Manager
Yi Yang	Secretary of the Board of Directors